Back to mobile site

RBC Capital Starts Charles River Labs (CRL) at Outperform, $215 PT

April 13, 2026 5:12 PM EDT Send to a Friend
RBC Capital analyst Ryan Halsted initiates coverage on Charles River Labs (NYSE: CRL) with a Outperform rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login